A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease

Project Number
EUJPND-European Commission-EC Grant-926
Agency/Funding Organization
European Commission
Funding Year
2016
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
EC Grant
Principal Investigator Last Name
EC Grant
Awardee Organization
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
$1,091,177
Funding Organization
Agency/Funding Organization
Funding Organization Country